3Indexed trials
drug · Product Intelligence
Lisdexamfetamine Dimesylate (LDX)
Pipeline Intelligence
Lisdexamfetamine Dimesylate (LDX): 3 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
1Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT00764868Shire · adhdPHASE3
NCT00784654Shire · adhdPHASE3
NCT01010750Shire · adhdPHASE1
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.